Results 111 to 120 of about 3,792 (182)

Quality of life of patients with fibrodysplasia ossificans progressiva [PDF]

, 2015

core   +1 more source

PI3Kα inhibition blocks osteochondroprogenitor specification and the hyper-inflammatory response to prevent heterotopic ossification [PDF]

Heterotopic ossification (HO) occurs following mechanical trauma and burns, or congenitally in patients suffering from fibrodysplasia ossificans progressiva (FOP).
Deber, Alexandre, Goumans, Marie-José, Pimenta-Lopes, Carolina, Rosa López, José Luis, Sánchez-Duffhues, Gonzalo, Valer, José Antonio, Ventura Pujol, Francesc, Wits, Marius   +7 more
core   +1 more source

Heterotope Ossifikation: Von der Ätiologie zur aktuellen Therapie [PDF]

, 2018
Zusammenfassung: Heterotope Ossifikationen werden als abnorme Bildung von Knochen in Weichteilgeweben definiert. Man unterscheidet die erworbene von den angeborenen Formen.
Bauer, S., Cadosch, D., Filgueira, L., Gautschi, O.P., Zellweger, R.   +4 more
core  

PMS72 Does oral cholecalciferol supplementation improves pain intensity and disability in patients with chronic low back pain? [PDF]

, 1930
Bansal, D., Ghai, B.
core   +1 more source

A case of fibrodysplasia ossificans progressiva with sternocleidomastoid muscle calcification [PDF]

Fibrodysplasia ossificans progressiva (FOP) is a rare and disabling genetic condition characterized by congenital skeletalmalformations and progressive heterotopic ossification in humans with no ethnic, racial, gender, or geographic predilection ...
Kumar, Kurrey Virendra, Rakesh, Nahrel
core   +1 more source

Fibrodysplasia ossificans progressiva [PDF]

, 2020
openaire   +3 more sources

Medical guidelines for fibrodysplasia ossificans progressiva. [PDF]

JBMR Plus
Kaplan FS, Al Mukaddam M, Baujat G, Hidalgo Bravo A, Brown M, Cali A, Cho TJ, Crowe C, De Cunto CL, Delai PLR, Diecidue RJ, Eekhoff EMW, Friedlander L, Friedman CS, Grunwald Z, Haga N, Hsiao EC, Keen R, Kitterman JA, Levy C, Madhuri V, Morhart R, Netelenbos JC, Scott C, Shore EM, Zasloff M, Zhang K, Pignolo RJ.   +27 more
europepmc   +1 more source

Identifying global trends from case reports of fibrodysplasia ossificans progressiva: a scoping review. [PDF]

Ther Adv Musculoskelet Dis
Scott C, Al Mukaddam M, Davis M, De Cunto CL, Hsiao EC, Pignolo RJ, Schwegler O, Artyomenko A, Croskery K, Hanman K, Sanchot B, Warnants E, Kaplan FS.   +12 more
europepmc   +1 more source

Bone Morphogenetic Proteins: An Update on Basic Biology and Clinical Relevance

, 1999
Amedee, Baker, Boden, Bostrom, Boyne, Brighton, Brighton, Bruder, Brunet, Caplan, Carcamo, Celeste, Celeste, Celeste, Chen, Chen, Clark, Cook, Cook, Cook, Cook, Cook, Ducy, Ducy, Dudley, Eppert, Geoffroy, Griffiths, Hartsough, Hata, Heldin, Hogan, Hollinger, Hollinger, Hollinger, Hollinger, Hollinger, Hoodless, Howell, Hsu, Hurley, Imamura, Ito, Jaiswal, Kania, Kaplan, Kim, Kingsley, Kingsley, Kingsley, Komori, Kretzschmar, Lagna, Liu, Liu, Lo, Long, Luo, Marden, Massagué, Massagué, Massagué, Mayer, Meyers, Mishina, Mucsi, Mundlos, Nakase, Newfeld, Nishimura, Nishitoh, Nohno, Ogawa, Ogawa, Onishi, Otto, Owen, Owen, Rao, Reddi, Reddi, Reddi, Reddi, Rickard, Ripamonti, Robinson, Rodan, Rosenzweig, Sakou, Savage, Sekelsky, Shafritz, Speck, Tabas, Takagi, Toriumi, Towler, Urist, Urist, Urist, Urist, Vaananen, Wang, Wang, Wang, Wang, Watanabe, Wiersdorff, Winn, Winn, Winnier, Wozney, Wozney, Wrana, Yamaguchi, Yamamoto, Yamashita, Yasko, Zegzula, Zhang, Zimmerman, Özkaynak, Özkaynak   +122 more
core   +1 more source

Compound KTI-2338 Inhibits ACVR1 Receptor Signaling in Fibrodysplasia Ossificans Progressiva. [PDF]

Pharmaceutics
Rosenberg NM, Zhytnik L, Wisse LE, Botman E, Lachey JL, Eekhoff EMW, Micha D.   +6 more
europepmc   +1 more source